Aringer M - Search Results

1

Treat-to-target in systemic lupus erythematosus: recommendations from an international task force.

van Vollenhoven RF, Mosca M, Bertsias G, Isenberg D, Kuhn A, Lerstrøm K, Aringer M, Bootsma H, Boumpas D, Bruce IN, Cervera R, Clarke A, Costedoat-Chalumeau N, Czirják L, Derksen R, Dörner T, Gordon C, Graninger W, Houssiau F, Inanc M, Jacobsen S, Jayne D, Jedryka-Goral A, Levitsky A, Levy R, Mariette X, Morand E, Navarra S, Neumann I, Rahman A, Rovensky J, Smolen J, Vasconcelos C, Voskuyl A, Voss A, Zakharova H, Zoma A, Schneider M. van Vollenhoven RF, et al. Among authors: aringer m. Ann Rheum Dis. 2014 Jun;73(6):958-67. doi: 10.1136/annrheumdis-2013-205139. Epub 2014 Apr 16. Ann Rheum Dis. 2014. PMID: 24739325

2

High levels of bcl-2 protein in circulating T lymphocytes, but not B lymphocytes, of patients with systemic lupus erythematosus.

Aringer M, Wintersberger W, Steiner CW, Kiener H, Presterl E, Jaeger U, Smolen JS, Graninger WB. Aringer M, et al. Arthritis Rheum. 1994 Oct;37(10):1423-30. doi: 10.1002/art.1780371004. Arthritis Rheum. 1994. PMID: 7945466

3

Severe infections in plasmapheresis-treated systemic lupus erythematosus.

Aringer M, Smolen JS, Graninger WB. Aringer M, et al. Arthritis Rheum. 1998 Mar;41(3):414-20. doi: 10.1002/1529-0131(199803)41:3<414::AID-ART6>3.0.CO;2-N. Arthritis Rheum. 1998. PMID: 9506568

4

Expression of adhesion molecules on synovial fluid and peripheral blood monocytes in patients with inflammatory joint disease and osteoarthritis.

Köller M, Aringer M, Kiener H, Erlacher L, Machold K, Eberl G, Studnicka-Benke A, Graninger W, Smolen J. Köller M, et al. Among authors: aringer m. Ann Rheum Dis. 1999 Nov;58(11):709-12. doi: 10.1136/ard.58.11.709. Ann Rheum Dis. 1999. PMID: 10531076 Free PMC article.

5

Cytokine regulation of apoptosis and Bcl-2 expression in lymphocytes of patients with systemic lupus erythematosus.

Graninger WB, Steiner CW, Graninger MT, Aringer M, Smolen JS. Graninger WB, et al. Among authors: aringer m. Cell Death Differ. 2000 Oct;7(10):966-72. doi: 10.1038/sj.cdd.4400724. Cell Death Differ. 2000. PMID: 11279543

6

Role of tumor necrosis factor alpha and potential benefit of tumor necrosis factor blockade treatment in systemic lupus erythematosus: comment on the editorial by Pisetsky.

Aringer M, Steiner G, Graninger W, Smolen J. Aringer M, et al. Arthritis Rheum. 2001 Jul;44(7):1721-2. doi: 10.1002/1529-0131(200107)44:7<1721::AID-ART302>3.0.CO;2-J. Arthritis Rheum. 2001. PMID: 11465728 Free article. No abstract available.

7

Serum interleukin-15 is elevated in systemic lupus erythematosus.

Aringer M, Stummvoll GH, Steiner G, Köller M, Steiner CW, Höfler E, Hiesberger H, Smolen JS, Graninger WB. Aringer M, et al. Rheumatology (Oxford). 2001 Aug;40(8):876-81. doi: 10.1093/rheumatology/40.8.876. Rheumatology (Oxford). 2001. PMID: 11511756

8

Treating rheumatoid arthritis with new disease modifying drugs.

Aringer M, Graninger WB. Aringer M, et al. Acta Med Austriaca. 2002;29(1):33-5. doi: 10.1046/j.1563-2571.2002.01042.x. Acta Med Austriaca. 2002. PMID: 11899752 Review.

9

SLE - Complex cytokine effects in a complex autoimmune disease: tumor necrosis factor in systemic lupus erythematosus.

Aringer M, Smolen JS. Aringer M, et al. Arthritis Res Ther. 2003;5(4):172-7. doi: 10.1186/ar770. Epub 2003 May 14. Arthritis Res Ther. 2003. PMID: 12823847 Free PMC article.

10

Increased transendothelial migration of scleroderma lymphocytes.

Stummvoll GH, Aringer M, Grisar J, Steiner CW, Smolen JS, Knobler R, Graninger WB. Stummvoll GH, et al. Among authors: aringer m. Ann Rheum Dis. 2004 May;63(5):569-74. doi: 10.1136/ard.2002.004838. Ann Rheum Dis. 2004. PMID: 15082489 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

302 results

Search Page